Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM

Clinical trial NCT05594797 · RECRUITING

Trial details

NCT number: NCT05594797
Sponsor: Hrain Biotechnology Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-07-12
Primary completion: 2025-07-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.